Table 2 Proportion and risk of CKD progression in patients with CKD stage 1–5, according to stain use.

From: Effect of Statins on Renal Function in Chronic Kidney Disease Patients

 

No. of events

No. of patients

Proportion (%)

Unadjusted odds ratio

Adjusted odds ratiob

Total

  Statin Users

237

825

28.73

0.93 (0.78, 1.10)

0.80 (0.63, 1.01)

  Statin Nonusers

793

2616

30.31

1.00

1.00

Stage 1–3a

  Statin Users

121

423

28.61

1.08 (0.85, 1.38)

0.97 (0.68, 1.39)

  Statin Nonusers

350

1294

27.05

1.00

1.00

Stage 3b-5

  Statin Users

116

402

28.86

0.81 (0.63, 1.03)

0.68 a (0.48, 0.95)

  Statin Nonusers

443

1322

33.51

1.00

1.00

  1. Note: Values in parentheses are 95% confidence interval.
  2. aP < 0.001.
  3. bAdjustments were made for age, sex, diabetes mellitus, coronary artery disease, stroke, cancer, Charlson comorbidity index, Statin drug used within 1 year before the index date, body mass index, smoking, alcohol, betel nut, urine protein and creatinine ratio, and baseline estimated glomerular filtration rate.
Back to article page